We studied multiple sclerosis (MS) patients with the HLA-DQB1*06:02 allele and compared them with MS patients who did not carry the HLA-DQB1*06:02 allele. We analyzed clinical and neurophysiological criteria for narcolepsy in six MS patients with HLA-DQB1*06:02, compared with 12 MS patients who were HLA-DQB1*06:02 non-carriers. Only two patients with HLA-DQB1*06:02 allele scored higher than 10 on the Epworth Sleepiness Scale. Polysomnography recording parameters and the multiple sleep latency test showed an absence of narcolepsy in the study group. Our study suggested no significant correlation between narcolepsy, MS and HLA-DQB1*06:02. The HLA-DQB1*06:02 allele alone was not sufficient to cause MS patients to develop narcolepsy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1590/0004-282X20170063 | DOI Listing |
Sleep Med
June 2021
National Reference Network for Narcolepsy, Sleep-Wake Disorders Unit, Department of Neurology, Gui-de- Chauliac Hospital, CHU Montpellier, Univ Montpellier, Institute of Neuroscience INM INSERM, Montpellier, France.
Background: There are limited data available on regional differences in the diagnosis and management of narcolepsy. In order to better understand worldwide trends in clinical assessment and management of narcolepsy, a survey of health-care providers was conducted by the World Sleep Society Narcolepsy task force.
Methods: A total of 146 surveys that included items on the diagnosis and management of narcolepsy were completed by practitioners representing 37 countries.
Eur J Paediatr Neurol
September 2020
Department of Neurology, Children's Health Ireland, Temple Street, Dublin, Ireland.
Aim: To describe the population of young people in Ireland diagnosed with narcolepsy with regards to vaccine exposure, symptomatology, investigation results and experience of medical treatment.
Method: Retrospective review of medical records at the single tertiary referral centre for young people with narcolepsy in Ireland.
Results: Sixty-seven patients were diagnosed with narcolepsy between July 2006 and July 2017.
Sleep Med
March 2012
Department of Pulmonary Medicine, Peking University People's Hospital, Beijing, China.
Objectives: Polymorphisms in the TCRA and P2RY11, two immune related genes, are associated with narcolepsy in Caucasians and Asians. In contrast, CPT1B/CHKB polymorphisms have only been shown to be associated with narcolepsy in Japanese, with replication in a small group of Koreans. Our aim was to study whether these polymorphisms are associated with narcolepsy and its clinical characteristics in Chinese patients with narcolepsy.
View Article and Find Full Text PDFEur J Paediatr Neurol
July 2011
Department of Neurology, 1st Faculty of Medicine and Teaching Hospital, Charles University, Prague, Czech Republic.
Background: Narcolepsy is a life-long disease characterized by abnormal regulation of the sleep-wake cycle and increased penetration of rapid eye movement (REM) sleep. In children, narcolepsy without cataplexy is more frequently seen than in adults. The aim of our study was to evaluate clinical and polysomnographic parameters to verify if cataplexy appearing later in life can be foretold.
View Article and Find Full Text PDFBrain Res
August 2007
Department of Psychobiology, Universidade Federal de São Paulo, Brazil.
Narcolepsy is a unique model for dysfunction in mechanisms that regulate sleep and wakefulness. The narcolepsy syndrome is characterized by excessive daytime sleepiness with recurrent episodes of irresistible sleep, cataplexy, hypnagogic and/or hypnopompic hallucinations and sleep paralysis. The current hypothesis for the etiology of narcolepsy is that it is an autoimmune disorder because of its strong association with the human leukocyte antigen (HLA) system.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!